Study of Aberrant Modifications in Peptides as a Test Bench to Investigate the Immunological Response to Non-Enzymatic Glycation
F. Nuti1, A. Gallo2, F. Real-Fernandez1, C. Rentier1,3, G. Rossi4,5, F. Piarulli2, P. Traldi6, S. Carganico1,5, P. Rovero4, Annunziata Lapolla2, Anna Maria Papini1,3
1Laboratory of Peptide and Protein Chemistry and Biology, Department of Chemistry „Ugo Schiff“, University of Florence, Sesto Fiorentino, Italy 2Diabetology and Dietetics, Department of Medicine (DIMED), University of Padova, Padova, Italy 3PeptLab@UCP Platform and Laboratory of Chemical Biology EA4505, University Paris-Seine, Cergy-Pontoise CEDEX, France 4Laboratory of Peptide and Protein Chemistry and Biology, Department of NeuroFarBa, University of Florence, Sesto Fiorentino, Italy 5Pharma Quality Europe PQE SrL, Località Prulli, Firenze, Italy 6Istituto di Ricerca Pediatrica, Città della Speranza, Padova, Italy
Received May 2019
Accepted June 2019
Crossref Cited-by Linking
Sharma Chiranjeev, Hamza Abu, Boyle Emily, Donu Dickson, Cen Yana: Post-Translational Modifications and Diabetes. Biomolecules2024, 14, 310. <https://doi.org/10.3390/biom14030310>
Takata Takanobu, Inoue Shinya, Masauji Togen, Miyazawa Katsuhito, Motoo Yoshiharu: Generation and Accumulation of Various Advanced Glycation End-Products in Cardiomyocytes May Induce Cardiovascular Disease. IJMS2024, 25, 7319. <https://doi.org/10.3390/ijms25137319>
Lapolla Annunziata: Thirty years of fruitful collaborations between a physician and mass spectrometrists in diabetes field. Mass Spectrometry Reviews2023, 42, 1086. <https://doi.org/10.1002/mas.21742>
